Trump's Tariff Threat: Generic Drugs Face 200% Hike by 2029
Former President Trump announces plans to impose steep tariffs on generic drugs, raising concerns over healthcare access and affordability.
In a controversial move, former President Trump has declared his intention to impose tariffs on generic drugs starting in August 2028. If implemented, these tariffs could reach a staggering 100 percent initially, escalating to 200 percent just a year later. This drastic measure raises urgent questions about the potential impact on healthcare costs for ordinary citizens across Europe.
The proposed tariffs come at a time when access to affordable medication is critical for many, particularly vulnerable populations who rely on generic medicines for their health needs. Critics are already voicing concerns, arguing that such tariffs could lead to skyrocketing prices and further exacerbate health inequalities.
As this story develops, citizens must ask: What assurances do governments have that they will protect access to essential medicines? Who will be held accountable if these tariffs lead to increased suffering among those already struggling to afford healthcare? These are pressing questions that demand answers from national governments and the European Union, as reported by Politico Europe.
Source: POLITICO Europe
